Luminex receives EUA for COVID-19 antibody test

Create PDF

The assay is designed to simultaneously detect antibodies against three antigens and delivers results for up to 96 patient samples in less than three hours. The test can run on any of Luminex’s xMAP-based high-throughput multiplex platforms.

The xMAP-based serology test is the third COVID-19 Luminex test to receive an EUA; the NxTAG CoV Extended Panel and the ARIES SARS-CoV-2 Assay received EUAs in March and April, respectively.